Clinical trial
Randomized Clinical Trial of Intranasal Dexamethasone as an Adjuvant in Patients With COVID-19
NCT04513184 is registered in ClinicalTrials.gov with Edda Sciutto Conde as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Randomized Clinical Trial of Intranasal Dexamethasone as an Adjuvant in Patients With COVID-19
- Lead sponsor
- Edda Sciutto Conde
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- November 5, 2021
- Completion date
- November 13, 2021
- Enrollment
- 66 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
covid19